Andrew D Barreto1, Andrei V Alexandrov. 1. Department of Neurology, Program, The University of Texas–Houston Medical School, Houston, TX, USA. andrew.d.barreto@uth.tmc.edu
Abstract
BACKGROUND AND PURPOSE: Current ischemic stroke reperfusion therapy consists of intravenous thrombolysis given in eligible patients after review of a noncontrast CT scan and a time-based window of opportunity. Rapid clot lysis has a strong association with clinical improvement but remains incomplete in many patients. This review appraises novel adjunctive or alternative approaches to current reperfusion strategies being tested in all trial phases. Summary of Review- Alternative approaches to current reperfusion therapy can be separated into 4 main categories: (1) combinatory approaches with other drugs or devices; (2) novel systemic thrombolytic agents; (3) endovascular medical or mechanical reperfusion treatments; and (4) noninvasive or minimally invasive methods to augment cerebral blood flow and alleviate intracranial blood flow steal. CONCLUSIONS: Reperfusion treatments must be provided as fast as possible in patients most likely to benefit. Patients who fail to rapidly reperfuse may benefit from other strategies that maintain collateral flow or protect tissue at risk.
BACKGROUND AND PURPOSE: Current ischemic stroke reperfusion therapy consists of intravenous thrombolysis given in eligible patients after review of a noncontrast CT scan and a time-based window of opportunity. Rapid clot lysis has a strong association with clinical improvement but remains incomplete in many patients. This review appraises novel adjunctive or alternative approaches to current reperfusion strategies being tested in all trial phases. Summary of Review- Alternative approaches to current reperfusion therapy can be separated into 4 main categories: (1) combinatory approaches with other drugs or devices; (2) novel systemic thrombolytic agents; (3) endovascular medical or mechanical reperfusion treatments; and (4) noninvasive or minimally invasive methods to augment cerebral blood flow and alleviate intracranial blood flow steal. CONCLUSIONS: Reperfusion treatments must be provided as fast as possible in patients most likely to benefit. Patients who fail to rapidly reperfuse may benefit from other strategies that maintain collateral flow or protect tissue at risk.
Authors: G J del Zoppo; K Poeck; M S Pessin; S M Wolpert; A J Furlan; A Ferbert; M J Alberts; J A Zivin; L Wechsler; O Busse Journal: Ann Neurol Date: 1992-07 Impact factor: 10.422
Authors: G R Thomas; H Thibodeaux; C J Errett; J M Badillo; B A Keyt; C J Refino; J A Zivin; W F Bennett Journal: Stroke Date: 1994-10 Impact factor: 7.914
Authors: I K Jang; D F Brown; R P Giugliano; H V Anderson; D Losordo; J C Nicolau; O P Dutra; O Bazzino; V M Viamonte; R Norbady; A S Liprandi; T J Massey; R Dinsmore; R P Schwarz Journal: J Am Coll Cardiol Date: 1999-06 Impact factor: 24.094
Authors: E M Ohman; N S Kleiman; G Gacioch; S J Worley; F I Navetta; J D Talley; H V Anderson; S G Ellis; M D Cohen; D Spriggs; M Miller; D Kereiakes; S Yakubov; M M Kitt; K N Sigmon; R M Califf; M W Krucoff; E J Topol Journal: Circulation Date: 1997-02-18 Impact factor: 29.690
Authors: Marian T Nakada; Michael O Montgomery; Mark A Nedelman; J Luis Guerrero; Sidney A Cohen; Elliot S Barnathan; Robert E Jordan Journal: J Vasc Interv Radiol Date: 2004-02 Impact factor: 3.464
Authors: Marian P LaMonte; Marshall L Nash; David Z Wang; Andrew R Woolfenden; John Schultz; Marcie J Hursting; Philip M Brown Journal: Stroke Date: 2004-05-20 Impact factor: 7.914
Authors: K Barlinn; J Seibt; K Engellandt; J Gerber; V Puetz; J Kepplinger; O Wunderlich; L-P Pallesen; U Bodechtel; R Koch; R von Kummer; I Dzialowski Journal: Clin Neuroradiol Date: 2014-08-23 Impact factor: 3.649
Authors: Madhuvanthi A Kandadai; Jason M Meunier; Kimberley Hart; Christy K Holland; George J Shaw Journal: Transl Stroke Res Date: 2014-11-20 Impact factor: 6.829
Authors: Kristian Barlinn; Andrew D Barreto; April Sisson; David S Liebeskind; Mark E Schafer; John Alleman; Limin Zhao; Loren Shen; Luis F Cava; Mohammad H Rahbar; James C Grotta; Andrei V Alexandrov Journal: Stroke Date: 2013-04-18 Impact factor: 7.914
Authors: Kristian Barlinn; Georgios Tsivgoulis; Andrew D Barreto; John Alleman; Carlos A Molina; Robert Mikulik; Maher Saqqur; Andrew M Demchuk; Peter D Schellinger; George Howard; Andrei V Alexandrov Journal: Int J Stroke Date: 2014-07-31 Impact factor: 5.266